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Introduction 
Natural products have been a valuable source of lead 
compounds in the drug discovery and development process.1 
Research on the synthesis of a specific natural product as a target 
molecule, that is target-oriented synthesis (TOS), has a long 
history in organic chemistry.2 In order to create the drugs based 
on the natural product structure, we need to synthesize structural 
analogues of the natural product, which cannot be obtained by 
the biosynthesis, and carry out the structure–activity relationship 
study. In this case, we have sometimes encountered a problem 
that we cannot supply the structural analogues from the natural 
product by the chemical synthesis, directly, due to its instability 
and incompatibility of its functional groups with the organic 
reaction conditions. The way to synthesize analogues of the 
natural product with avoiding the difficulty mentioned above is 
to derivatize the advanced intermediate in total synthesis of the 
natural product to the target analogues. This approach of 
preparing the analogues is called as diverted total synthesis 
(DTS), which was proposed by Danishefsky.3 In contrast to TOS, 
diversity-oriented synthesis (DOS), which was proposed by 
Schreiber,4 aims to populate chemical space broadly with small 
molecules having skeletal and stereochemical diversity. In the 
strategy of DOS, the structural complexity of each compounds 
and the structural diversity of the overall synthetic scheme are 
maximized, and the synthetic pathway is branched and divergent. 
Many natural products coexist with their stereoisomers as 
congeners to each other. It is significant to develop the efficient 
synthetic route to access to all stereoisomers of the natural 
product from the point of view of both structural 
confirmation/elucidation and structure–activity relationship 
study. There are mainly two kinds of synthetic strategy to reach 
the target compounds 1a–1d possessing two chiral centers, as 
described in Scheme 1.5 In the independent pathway (a), four 
target compounds 1a–1d are synthesized from the different 
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starting materials, independently and respectively. In the 
divergent pathway (b),6 1a–1d are synthesized from the same 
starting material. In this synthetic route, 2a and 2b are 
synthesized by branching from the common intermediate (first 
stereodiversification). In addition, 1a,1b and 1c,1d are 
synthesized from the common intermediates prepared from 2a 
and 2b, respectively (second stereodiversification). In this 
stereodivergent synthesis, all four target compounds 1a–1d are 
supplied in a unified manner, and setting the branching point 
from the common synthetic intermediates at the late-stage of 
synthesis makes the whole synthetic scheme more efficient 
because of decreasing the number of overall steps. In this digest, 
selected examples of the stereodivergent approach toward the 
synthesis of natural products, which were published during the 
past five years, are presented. This digest focuses on common 
synthetic intermediates and stereodiversification steps from the 
common intermediates for delivering stereoisomers. 
Scheme 1. Two kinds of synthetic strategy toward 1a–1d 
bearing two chiral centers. 
Breit’s synthesis of helicascolides A, B, and C7 
In addition to the lactonization by activation of 
hydroxycarboxylic acids,8 transition metal-catalyzed addition 
reaction,9 halo- and selenolactonization,10 and ring-closing 
metathesis11 have been reported as the synthetic methods for the 
five- or six-membered lactones. Breit and co-workers developed 
regio- and enantioselective rhodium-catalyzed addition of 
carboxylic acids to allenes in 2011.12 This research group 
investigated the protecting-group-free synthesis of six-
membered lactone natural products, helicascolide A (3a, Figure 
1),13a its C3 epimer helicascolide B (3b),13a and C3 ketone 
helicascolide C (4).7,13b 
Figure 1. Structures of helicascolides A (3a), B (3b), and C (4). 
As shown in Scheme 2, addition reaction of enolate, derived 
from ester 5 with lithium diisopropylamide (LDA), and aldehyde 
6 provided C3 stereoisomers 7a and 7b, divergently, in 80% 
combined yield with a 1:1 diastereomeric ratio. After the tert-
butyl ester 7a was transformed to the corresponding carboxylic 
acid with trifluoroacetic acid (TFA), intramolecular 
hydrooxycarbonylation of carboxylic acid to allene was 
investigated. Thus, when the carboxylic acid prepared from 7a 
was subjected to the original reaction conditions,12 the 
combination of [Rh(cod)Cl]2 and DPEphos, the desired product 
8a was obtained in 78% yield as a single diastereomer. It is 
noteworthy that the hydroxy functional group at the C3 position 
was compatible with the reaction conditions and the C5 chiral 
center was installed by the substrate-control without adding the 
chiral ligand. When the intramolecular hydrooxycarbonylation 
of 7b was carried out by using the same reaction system, six-
membered lactone 8b was produced as a major diastereomer (dr 
= 90:10), albeit in low chemical yield (20%). After the survey of 
reaction conditions for 7b, it was found that the use of 
[Rh(cod)Cl]2 and (S,S)-diop as a chiral ligand was effective and 
the product 8b was obtained in 54% yield and diastereomeric 
ratio of 89:11. The alkenes 8a and 8b were oxidized to 9a and 
9b in the presence of PdCl2/1,4-benzoquinone, respectively.14 
The remaining task is to construct the trisubstituted alkene 
moieties. Treatment of the ketone 9a with Ph3P+EtBr–/potassium 
hexamethyldisilazide (KHMDS) gave the undesired (Z)-alkene 
as a single geometric isomer. Since attempts for the (E)-selective 
olefination of 9a resulted in failure, one extra transformation was 
needed to obtain helicascolde A (3a). Thus, radical-mediated 
isomerization of double bond of the (Z)-alkene was performed 
with PhSH/2,2’-azobisisobutyronitrile (AIBN) to yield 
helicascolide A (3a) in an E/Z ratio of 6:1. In contrast, (E)-
selective olefination of the ketone 9b was achieved with 
Ph3P+EtBr–/LiHMDS to give helicascolide B (3b) in an E/Z ratio 
of 13:1. Finally, stereoconvergent synthesis of helicascolide C 
(4) was achieved by oxidation of 3a and 3b with Dess–Martin 
periodinane (DMP). 
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Scheme 2. Stereodivergent synthesis of 3a and 3b, and 
stereoconvergent synthesis of 4. 
Kim’s synthesis of 2,5-cis- and trans-tetrahydrofuranoid 
oxylipids15 
The marine oxylipids 10a and 10b (Figure 2) were isolated 
from the Australian brown algae Notheia anomata.16 They have 
the 2,5-disubstituted-3-hydroxylated tetrahydrofuran (THF) unit 
as a common framework, furthermore, possess a structural 
diversity, that is, 10a and 10b bear the 2,5-cis- and trans-
disubstituted THF moieties, respectively. Interestingly, both 10a 
and 10b exhibit the nematocidal activity with similar LD50 
values without regard to the stereochemical difference. Kim’s 
research group applied their originally developed stereodivergent 
intramolecular amide enolate alkylation (IAEA)17 to the total 
synthesis of 10a and 10b.15 
Figure 2. Structures of 2,5-disubstituted-3-hydroxylated 
tetrahydrofurans 10a and 10b. 
First, alcohol 11, which is the common intermediate toward 
the synthesis of 10a and 10b, was transformed to p-methoxy 
benzyl (PMB) ether 12a and triisopropylsilyl (TIPS) ether 12b, 
respectively (Scheme 3). Next, IAEA reaction of the PMB ether 
12a, leading to the cis-disubstituted THF 10a, was examined in 
terms of base (LiHMDS, NaHMDS, and KHMDS), solvent 
(THF and toluene), and temperature, and it was proven that 
treatment of 12a with KHMDS in THF at –78 °C gave the 
desired cis-disubstituted THF 13a in 94% yield as a single 
diastereomer. On the other hand, when the TIPS ether 12b was 
subjected to the same reaction conditions, trans-disubstituted 
THF 13b, which is the C9 epimer of 13a, was produced in 95% 
yield at a 71:1 diastereomeric ratio. The use of other silyl 
protecting groups such as tert-butyldimethylsilyl (TBS), 
triethylsilyl (TES), and trimethylsilyl (TMS) caused lowering the 
diastereoselectivity. The stereochemical outcomes in the 
formation of 13a and 13b are understandable by using transition 
states as described in Scheme 4. Thus, in the case of IAEA 
reaction of 12a, the reaction would proceed through transition 
state TS1, wherein the p-methoxy benzyloxy group could 
participate in the chelation, to provide the cis-disubstituted THF 
13a. In contrast, the observed diastereoselectivity in the reaction 
of 12b could be rationalized by nonchelate transition state TS2, 
which minimizes a steric repulsion between the bulky TIPS-
protected hydroxy group and the amide enolate moiety. As 
described in Scheme 3, the left side chains were introduced by 
the reaction of the amides 13a and 13b with 
CH2=CH(CH2)7MgBr and subsequent diastereoselective 
reduction of the resulting ketones with L-Selectride to furnish 
alcohols 14a and 14b, respectively. Deprotection of the PMB 
ether 14a and the TIPS ether 14b produced the target compounds 
10a and 10b. 
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Scheme 3. Stereodivergent synthesis of 10a and 10b. 
Scheme 4. Plausible transition states in the IAEA reaction of 
12a and 12b. 
Porco’s synthesis of sanggenons C and O18 
Sanggenons C (15a, Figure 3) and O (15b) are flavonoid 
natural products isolated from the traditional Chinese herbal 
medicine “Sag-bai-pi” and the root bark of Chinese mulberry 
tree Morus cathayana.19 These two natural products have the 
stereoisomeric relationship at the C2 and C3 positions. Their 
cyclohexene moieties are proposed to be biosynthetically 
produced by Diels–Alder reactions between a dehydroprenylated 
flavanone and a chalcone. Porco and co-workers tried the total 
synthesis of sanggenons C (15a) and O (15b) by employing 
stereodivergent reaction of a racemic mixture.18,20 
First, double Claisen rearrangement of 16 with rare earth 
metal triflates was examined and Yb(OTf)3 was found to give 
the desired double rearranged product 17 in 72% yield (Scheme 
5). After protection of 17 with TBSOTf/Et3N, cross-metathesis 
of the resulting diene with isobutene by using second generation 
Grubbs catalyst afforded prenylated product 18 in 92% yield in 
two steps. The obtained 18 was dehydrogenated with 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) to provide 
pentacyclic compound 19. Porco and co-workers expected that 
the benzopyran 19 could undergo retro 6π electrocyclization to 
yield diene 20, which could give the desired diene 21 via 
deprotonation/protonation. If this scenario would be realized, 
Diels–Alder products between the diene 21 and a dienophile 
could be formed. Furthermore, they considered that sanggenons 
C (15a) and O (15b) are both endo-adducts and possess the same 
absolute configuration in the cyclohexene moiety. Therefore, 
they envisioned that enantioselective Diels–Alder reaction 
between the racemic 21 and a dienophile could produce both of 
sanggenons C (15a) and O (15b) with the C2 and C3 
stereoisomeric relationship in a stereodivergent manner. Thus, a 
screening of reaction conditions was conducted using a number 
of borates and 1,1’-bi-2-naphthol (BINOL) ligands. Finally, 
treatment of the racemic 19 with 2’-hydroxychalcone 22 in the 
presence of a catalytic amount of B(OPh)3/(R)-3,3’-dibromo-
BINOL 23 afforded two desired endo-cycloadducts. These two 
products were deprotected with aq. NaHCO3 and 3HF∙Et3N to 
produce sanggenons C (15a, 98% ee) and O (15b, 93% ee) in 
54% combined yield in three steps with a 2:1 ratio. 
Figure 3. Structures of sanggenons C (15a) and O (15b). 
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Scheme 5. Stereodivergent synthesis of 15a and 15b. 
Nishiyama’s synthesis of hemifistularin 3 for the structural 
elucidation21 
Hemifistularin 3 (24, Figure 4) is an antifouling natural 
product isolated from a sponge of the order Verongida.22 
Although the detailed NMR analysis revealed the relative 
configuration at the C12 oxygen atom and the C17 hydroxy 
group to be trans, the stereochemistry at the C7 position, which 
is a chiral center remote from the C12 and C17 positions, 
remained to be clarified. Nishiyama’s group investigated the 
stereodivergent synthetic approach to hemifistularin 3 (24) 
aiming at its structural determination.21 
Enantiomerically pure spiroisoxazolines 25a and 25b were 
prepared by the optical resolution. Thus, reaction of racemic 25 
with (–)-camphanic chloride followed by recrystallization gave 
diastereomeric isomers 26a and 26b, which were treated with 
Cs2CO3 in MeOH to afford enantiomeric isomers 25a and 25b, 
respectively (Scheme 6). Condensation of the ester 25a and 
amines 27a,27b, and subsequent removal of the PMB groups 
with TFA provided the C7 diastereomeric isomers 24a and 24b, 
respectively. In the similar way, the ester 25b was transformed 
to 24c and 24d. The synthetic products 24a and 24b exhibited 
the positive signs of specific rotation (24a: +125, 24b: +130) in 
comparison with that of natural hemifistularin 3 (+110), which 
established that the natural product has the (12S,17R)-absolute 
configuration. However, small difference of the specific 
rotations and spectroscopic data between 24a and 24b could not 
lead to the structural elucidation of the natural product. 
Figure 4. Relative configuration of hemifistularin 3 (24). The 
stereochemistry at the C7 position was unknown. 
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Scheme 6. Stereodivergent synthesis of 24a–24d. 
The isolation paper22a reported that alkaline degradation of 
11-oxofistularin 3 (28) produced oxime 29 along with 
hemifistularin 3 (24), as described in Scheme 7. The formation 
of 29 is understandable by ring-opening of spiroisoxazole 
moieties of 28 or 24. This observation indicates that the C7 
stereochemistry of 29 is same as that of 24. Therefore, 
Nishiyama and co-workers next examined the synthesis of 
possible stereoisomers of 29. Reaction of ester 30 with the 
amines 27a and 27b followed by deprotection of PMB ethers 
furnished 29a and 29b, respectively (Scheme 8). Comparison of 
the specific rotations between the synthetic products (29a: +6.7, 
29b: –6.3) and the degraded product 29 (+20) elucidated the 
absolute stereochemistry of hemifistularin 3 (24) to be 
(7S,12S,17R) as depicted in 24a. 
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Scheme 7. Alkaline degradation of 11-oxofistularin 3 (28). 
Scheme 8. Stereodivergent synthesis of 29a and 29b. 
Pietruszka’s synthesis of solandelactone I for the structural 
elucidation23 
Solandelactone I (31, Figure 5), which possesses the 
cyclopropyl and lactone moieties as a structural feature, was 
isolated from the hydroid Solanderia secunda in 1996.24 The 
relative configuration at the C7, C8, and C10 positions of the 
cyclopropyl and lactone portions was determined by the nuclear 
Overhauser effect (NOE) observations. However, the 
stereochemistry of the vicinal diol group at the C13 and C14 
positions was not elucidated. Therefore, Pietruszka and co-
workers tried to synthesize all four possible diastereomers of 
solandelactone I (31).23 
Figure 5. Relative configuration of solandelactone I (31). The 
stereochemistries at the C13 and C14 positions were unknown. 
Horner–Wadsworth–Emmons reaction between aldehyde 3225 
and phosphonates 33a and 33b, which were respectively 
prepared from L- and D-serines in optically pure forms, afforded 
α,β-unsaturated ketones 34a and 34b (Scheme 9). This is the 
first branching point to deliver the C14 stereoisomers. Next task 
is to supply the C13 stereoisomers by the second branching. 
Thus, the Felkin–Anh type 1,2-reduction utilizing the C14 chiral 
center of 34a with NaBH4/CeCl3 followed by removal of the 
TBS protecting group gave syn-diol 31a. In addition, after the 
deprotection of the TBS ether 34a, the chelation-controlled 
diastereoselective reduction of the resulting α-hydroxy ketone 
with Zn(BH4)2 produced anti-diol 31b. In parallel, the α-siloxy 
ketone 34b was converted to syn-diol 31c and anti-diol 31d by 
the diastereoselective reduction, respectively. The detailed NMR 
comparison between the synthesized products 31a–31d and 
natural solandelactone I revealed that 31c exhibits a better match 
with the natural product data. The specific rotation of 31c was –
48.6 (c = 0.50, MeOH), which was agreement with that for the 
natural product, –37.0 (c = 0.50, MeOH). Therefore, the absolute 
configuration of natural solandelactone I was elucidated to be 
that described in 31c. This structural assignment is supported by 
the proposed biosynthesis of solandelactones.24 
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Scheme 9. Stereodivergent synthesis of 31a–31d. 
Takamura’s synthesis of the C79–C104 fragment of 
symbiodinolide for the structural elucidation26 
Symbiodinolide (35, Figure 6), a polyol marine natural 
product, was isolated from the cultured dinoflagellate 
Symbiodinium sp. in 2007.27 The planar structure of 35 was 
elucidated by the detailed 2D NMR analysis. However, the 
complete stereochemical determination of 35 remains an 
unsolved issue due to its huge and complicated molecular 
structure characterized by a molecular weight of 2,860 and 61 
stereogenic centers. The stereochemistries in the C91–C99 
carbon chain portion of 35 were assigned by the 3JH,H coupling 
constants and NOE observations of the natural product.27 
Takamura’s research group investigated stereoselective synthesis 
of the C79–C104 fragment 36a bearing the proposed relative 
configuration. 
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Figure 6. Structures of symbiodinolide (35) and its proposed C79–C104 fragment 36a. 
The stereoselective and streamlined synthesis of the C79–
C104 fragment 36a possessing the proposed stereostructure was 
achieved by using Julia–Kocienski olefination between PT-
sulfone 37 and aldehyde 38 and subsequent Sharpless 
asymmetric dihydroxylation (Scheme 10). Comparison of the 13C 
NMR data between the synthetic product 36a and the natural 
product revealed that the stereochemistry of the C91–C99 carbon 
chain moiety of 35 should be reinvestigated.26a 
Scheme 10. Stereoselective synthesis of 36a. 
Since there are seven chiral centers in the C91–C99 carbon 
chain portion, the number of possible diastereomers of this 
moiety is 26 = 64. If all these possible 64 diastereomers could be 
synthesized, the stereostructure of this part might be elucidated 
by comparing the NMR data between the synthetic products and 
the natural product. However, the supply of 64 diastereomers by 
chemical synthesis would require a substantial amount of work. 
Therefore, toward the structural determination of the C79–C104 
fragment, Takamura and co-workers divided the C79–C104 
fragment 36 into the C79–C97 fragment 39 and the C94–C104 
fragment 40 (Scheme 11). Thus, in this plan, after the 
configurational determination of each of the C79–C97 fragment 
39 and the C94–C104 fragment 40, the relative configuration of 
the C79–C104 fragment 36 would be assigned by connecting 
each stereostructure of the C79–C97 fragment 39 and the C94–
C104 fragment 40 by the C95 stereochemistry contained in both 
fragments. 
Scheme 11. Strategy for the stereostructural elucidation of the 
C94–C104 fragment 36. 
The C79–C97 fragment 39 possesses three chiral centers in 
the carbon chain portion (C93, C94, and C95), therefore, there 
are eight possible diastereomers of this fragment (Figure 7). 
Stereodivergent synthesis of all these eight diastereomers 39a–
39h was examined. Thus, reaction of aldehyde 41 and dithiane 
42 gave C93 stereoisomers 43a and 43b in a 1:1 diastereomeric 
ratio (Scheme 12). The dithiane moiety of 43a was hydrolyzed 
to afford ketone 44, which is a common synthetic intermediate 
for the synthesis of 39a and 39b. After the TBS protection of 44, 
the Felkin–Anh type reduction of the resulting α-siloxy ketone 
by utilizing the C93 stereochemistry was performed with 
Tetrahedron Letters 10 
diisobutylaluminum hydride (DIBAL-H) to provide alcohol 
45a as a sole product. Finally, deprotection of 45a produced the 
tetraol 39a. Next, the chelation-controlled reduction of the α-
hydroxy ketone 44 was successfully carried out with L-
Selectride in the presence of ZnCl2 as a chelating reagent28 to 
furnish anti-diol 45b in 86% yield. The protecting groups of 45b 
was removed to give the tetraol 39b, which is the C94 epimer of 
39a. In parallel, both of 39c and 39d were synthesized from the 
alcohol 43b, stereodivergently. In addition, other diastereomers 
39e–39h were also supplied by using the enantiomer of 42 in a 
similar way. Comparison of the 13C NMR data between the 
synthetic products 39a–39h and natural product 35 turned out 
the relative configuration of the C79–C97 fragment of the 
natural product to be that depicted in either 39a or 39f. 
Figure 7. Eight possible diastereomers of the C79–C97 fragment. 
Scheme 12. Stereodivergent synthesis of 39a–39d. 
As in the case of the C79–C97 fragment 39, there are eight 
possible diastereomers of the C94–C104 fragment 40 because of 
the presence of three stereogenic centers in the carbon chain 
moiety (C95, C97, and C98, Figure 8). Therefore, sereodivergent 
synthesis of all these diastereomers 40a–40h was pursued. 
Hydrolysis of the dithiane moiety of 46 provided α-hydroxy 
ketone 47 (Scheme 13). The chelation-controlled 
diastereoselective reduction of 47 with Zn(BH4)2 followed by 
deprotection of the resulting 48a afforded the hexaol 40a. On the 
other hand, the hexaol 40b, which is the C97 epimer of 40a, was 
delivered by the Felkin–Anh controlled diastereoselective 
reduction of α-siloxy ketone prepared from 47 with DIBAL-H 
and subsequent deprotection of 48b. Other six hexaols 40c–40h 
were also synthesized in a stereodivergent way. Comparison of 
the 13C NMR data of the synthetic 40a–40h with those of the 
natural product revealed the relative stereochemistry of the C94–
C104 fragment of natural product 35 to be that shown in either 
40a or 40e. 
Figure 8. Eight possible diastereomers of the C94–C104 
fragment. 
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Scheme 13. Stereodivergent synthesis of 40a and 40b. 
By connecting the relative configurations of the C79–C97 
fragment (39a or 39f) and the C94–C104 fragment (40a or 40e) 
through the C95 chiral center, four candidate compounds of the 
C79–C104 fragment were proposed as drawn in Scheme 14; 36a 
(39a + 40a), 36b (ent-39a + 40e), 36c (ent-39f + 40a), and 36d 
(39f + 40e). Toward the stereostructural elucidation of the C79–
C104 fragment, the unified synthesis of 36a–36d was tried (For 
the synthesis of 36a, see Scheme 10). The 93,94-syn-diol 36b 
was synthesized by Julia–Kocienski olefination and Sharpless 
asymmetric dihydroxylation of the (E)-alkene. The 93,94-anti-
diols 36c and 36d were supplied by Wittig reaction and 
Sharpless asymmetric dihydroxylation of the (Z)-alkenes, 
respectively. Detailed comparison of their 13C NMR data with 
those of the natural product elucidated that the relative 
stereochemistry of the C79–C104 fragment of symbiodinolide 
(35) to be that depicted in 36b.26b 
Scheme 14. Four candidate compounds of the C79–C104 fragment. 
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Takamura and Kadota’s synthesis of gummiferol for the 
structural elucidation and the structure–activity relationship 
study29 
Gummiferol (49, Figure 9) was isolated from the leaves of 
Adenia gummifera.30 This natural product exhibits a cytotoxicity 
against 13 mammalian cencer cell lines including strong activity 
against P388 murine leukemia cells and U373 human glioma 
cells. The planar structure of gummiferol, which has featured the 
conjugated triacetylene moiety and its neighboring diepoxide 
portion, was elucidated by the analyses of HRMS, IR, UV, and 
2D NMR spectra. The trans-configurations at the C8/C9 and 
C10/C11 epoxide moieties were determined by the coupling 
constants of 3JH,H, respectively. However, the absolute 
stereostructure of the diepoxide portion at the C8 to C11 
positions was not clarified. Therefore, Takamura and Kadota’s 
research group examined the synthesis of all four possible 
stereoisomers of gummiferol (49) toward its stereochemical 
elucidation.29 
Figure 9. Planar structure of gummiferol (49). 
This research group introduced the stereochemistries at the 
C8 to C11 positions by utilizing the stepwise Sharpless 
asymmetric epoxidation,31 stereoselectively and respectively. 
Thus, as shown in Scheme 15, treatment of dienol 50 with (+)-
diisopropyl tartrate (DIPT) and (–)-DIPT in the presence of 
Ti(Oi-Pr)4/tert-butyl hydroperoxide (TBHP)/molecular sieves 
(MS) 4Å afforded epoxy alcohols 51a and 51b as a single 
stereoisomer, respectively. The absolute stereochemistry of the 
synthetic 51a was confirmed by epoxide ring-opening at the 
allylic C11 position of 51a with Red-Al32 and subsequent 
modified Mosher method.33 After two-carbon elongation of the 
alcohols 51a,51b was carried out in three steps to provide allylic 
alcohols 52a,52b, syn- and anti-diepoxides 53a,53c and 53b,53d 
were synthesized as a single diastereomer, respectively, by 
applying Sharpless asymmetric epoxidation31 to 52a,52b. The 
diepoxy alcohols 53a–53d were transformed to bromoacetylenes 
54a–54d in a parallel synthesis. Finally, construction of the 
triacetylene moieties by using Cadiot–Chodkiewicz coupling34 
between 54a–54d and diacetylene 55 was performed to produce 
all four possible stereoisomers of gummiferol, 49a–49d. 
Detailed comparison of the NMR data and specific rotations 
between the synthetic 49a–49d and the natural product revealed 
the absolute configuration of natural (–)-gummiferol to be that 
described in 49a. 
Scheme 15. Stereodivergent synthesis of 49a–49d. 
Next, the growth-inhibitory activity of the synthetic products 
against HL60 human leukemia cells and HeLa S3 human 
cervical cancer cells was evaluated. Interestingly, (–)-
gummiferol (49a) and its stereoisomers 49b–49d exhibited the 
similar activity without regard to the stereochemistry of the 
diepoxide portion (Figure 10). The truncated diepoxide analogue 
56 was inactive against both HL60 and HeLa S3 cells. On the 
other hand, the structurally simplified triacetylene analogues 57–
62 retained the cytotoxic activity against both HL60 and HeLa 
S3 cells. These results elucidated the following two points about 
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the structure–activity relationship: (1) The stereostructure of the 
diepoxide unit has little influence on the cytotoxicity. (2) The 
triacetylene moiety is essential for exerting the cytotoxicity. 
Figure 10. IC50 Values of the synthetic gummiferol and its analogues against human cancer cells. 
Conclusion 
This digest summarizes recent topics of stereodivergent 
synthesis of natural products. In the divergent synthesis, it is 
necessary to synthesize more than one target compound. In other 
words, stereodivergent synthesis cannot be realized if even one 
of target compounds is lacking. This significant issue needs to be 
deeply considered in planning the stereodivergent synthetic route. 
In addition, common synthetic intermediates and 
stereodiversification steps from common intermediates should be 
taken into account. Thus, setting stereodiversification steps at the 
late-stage of synthesis leads to proposal of the efficient synthetic 
scheme due to decreasing the number of total steps required for 
delivery of all target compounds. To supply all stereoisomers of 
natural products in a divergent manner accelerates structural 
elucidation and stereostructure–activity relationship study of 
natural products, and also provides the opportunity to develop 
the novel synthetic strategy and reaction.35 It is expected that the 
stereodivergent strategy will be more and more utilized in the 
synthesis of not only natural products but also agrochemicals, 
pharmaceuticals, and organic materials. 
∗ Corresponding author. Tel.: +81-86-251-7839; E-mail: 
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